Clinical trial
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin…
NCT00352612 · Aaron Chen, Other · Completed
Key facts
| NCT number | NCT00352612 |
|---|---|
| Title | Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections |
| Official title | Comparison of Cephalexin Versus Clindamycin in the Empiric, Outpatient Treatment of Suspected Staphylococcal Cutaneous Infections in the Era of Community-associated Methicillin-resistant Staphylococcus Aureus (CA-MRSA) |
| Lead sponsor | Aaron Chen, Other |
| Collaborators | Thrasher Research Fund Johns Hopkins University |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Staphylococcal Infection, Abscess, Staphylococcal Skin Infection, Folliculitis |
| Intervention type | Drug |
| Interventions | clindamycin, cephalexin |
| Enrollment | 200 |
| Start date | Sep 1, 2006 |
| Primary completion | May 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Jul 14, 2006 |
| Last update posted | May 13, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: